0001628280-24-023605.txt : 20240515
0001628280-24-023605.hdr.sgml : 20240515
20240515163656
ACCESSION NUMBER: 0001628280-24-023605
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240513
FILED AS OF DATE: 20240515
DATE AS OF CHANGE: 20240515
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schaeffer Orlov S Nicole
CENTRAL INDEX KEY: 0001401017
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30739
FILM NUMBER: 24951911
MAIL ADDRESS:
STREET 1: INSMED INCORPORATED
STREET 2: 10 FINDERNE AVENUE
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INSMED Inc
CENTRAL INDEX KEY: 0001104506
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 541972729
STATE OF INCORPORATION: VA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 700 US HIGHWAY 202/206
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
BUSINESS PHONE: 908-977-9900
MAIL ADDRESS:
STREET 1: 700 US HIGHWAY 202/206
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER COMPANY:
FORMER CONFORMED NAME: INSMED INC
DATE OF NAME CHANGE: 20000128
4
1
wk-form4_1715805404.xml
FORM 4
X0508
4
2024-05-13
0
0001104506
INSMED Inc
INSM
0001401017
Schaeffer Orlov S Nicole
700 US 202/206
BRIDGEWATER
NJ
08807
0
1
0
0
Chief People Strategy Officer
0
Common Stock
2024-05-13
4
A
0
13308
A
115268
D
Common Stock
2024-05-14
4
S
0
6508
25.53
D
108760
D
Stock Option (right to buy)
25.83
2024-05-13
4
A
0
65230
0
A
2034-05-13
Common Stock
65230
65230
D
Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% percent on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.
Each RSU was granted on May 13, 2024 for no consideration.
Due to a clerical error related to the reporting of shares previously withheld by the Company to satisfy tax obligations upon the vesting of RSUs, this number was previously overstated by 24 shares. This value reflects the adjustment, decreasing the amount beneficially owned by 24 shares.
Shares sold to satisfy withholding tax obligations upon the vesting of RSUs and to cover related broker fees.
This is the weighted average sales price representing 6,508 shares sold at prices ranging from $25.50 to $25.55 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter through the fourth anniversary of the Initial Vesting Date.
/s/ S. Nicole Schaeffer, by Michael A. Smith as Attorney-in-fact
2024-05-15